Free Trial
OTCMKTS:BFNH

BioForce Nanosciences Q4 2024 Earnings Results & Report

BioForce Nanosciences logo
$8.25 -0.15 (-1.79%)
As of 10:04 AM Eastern

BioForce Nanosciences reported Q4 2024 earnings on April 8, 2025. The company reported EPS of -$0.01.

Earnings Announcement Details

Quarter
Q4 2024
Report Date
Time
After Market Closes

BioForce Nanosciences EPS Results

Actual EPS
-$0.01
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

BioForce Nanosciences Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Conference Call Resources

BioForce Nanosciences Q4 2024 Earnings FAQ

BioForce Nanosciences (OTCMKTS:BFNH) reported earnings of -$0.01 per share for Q4 2024. The report was announced on Tuesday, April 8, 2025.

BioForce Nanosciences Earnings Headlines

The REAL Reason Trump is Invading Iran
For a moment… Forget about Trump’s ties to Israel. Forget about reports of Iran’s nuclear program. Because my research has led me to believe we’re risking World War 3 with Iran for a completely different reason.tc pixel
BioForce Nanosciences Delays Annual 10-K Filing
See More BioForce Nanosciences Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like BioForce Nanosciences? Sign up for Earnings360's daily newsletter to receive timely earnings updates on BioForce Nanosciences and other key companies, straight to your email.

About BioForce Nanosciences

BioForce Nanosciences (OTCMKTS:BFNH), Inc. develops nanotechnology tools and systems designed for research in life sciences, materials science and related fields. The company’s technologies are intended to support the controlled manipulation, deposition and analysis of very small quantities of biological and chemical materials.

Its product portfolio has included nanoscale patterning and fluid-handling systems, including the Nano eNabler platform. These tools are designed for applications such as creating biological arrays, depositing samples and reagents, and conducting research involving cells, proteins, DNA and other materials at the micro- and nanoscale.

BioForce Nanosciences was based in the United States and focused primarily on serving scientific, academic and industrial research markets. Publicly available information about its current operations, geographic reach and leadership is limited.

View BioForce Nanosciences Profile